Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Sarcoma × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15 Other hematologic neoplasm 4 Head & Neck 4 Lymphoid 2 Gynecologic 2 Sarcoma 1 Other 1 Genitourinary 1 CNS 1

Conditions

Sarcoma 189 Bone Neoplasms 53 Breast Neoplasms 38 Neoplasms 34 Osteosarcoma 32 Lymphoma 30 Gastrointestinal Stromal Tumors 28 Dendritic Cell Sarcoma, Interdigitating 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Hodgkin Disease 25 Leukemia 24 Lymphoma, Non-Hodgkin 23 Melanoma 22 Brain Neoplasms 22 Multiple Myeloma 21 Burkitt Lymphoma 21 Leukemia, Myeloid, Acute 20 Glioblastoma 20 Sarcoma, Ewing 19 Recurrence 19 Lymphoma, Mantle-Cell 18 Lymphoma, Large B-Cell, Diffuse 18 Prostatic Neoplasms 17 Pancreatic Neoplasms 17 Neuroblastoma 17 Lymphoma, Follicular 17 Leukemia, Lymphocytic, Chronic, B-Cell 17 Gliosarcoma 17 Leukemia, Myeloid, Chronic-Phase 16 Leukemia, Myeloid, Accelerated Phase 16

Interventions

pimonidazole 1 fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting

Hypoxia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡